CLINICAL IMMUNOLOGY
Terminally differentiated memory T cells are increased in patients with common variable immunodeficiency and selective IgA deficiency
More details
Hide details
Submission date: 2016-01-11
Acceptance date: 2016-02-02
Publication date: 2017-10-30
Cent Eur J Immunol 2017;42(3):244-251
KEYWORDS
ABSTRACT
Introduction: Previous studies showed that several lymphocyte abnormalities seen in the most frequent symptomatic immunoglobulin deficiency, common variable immunodeficiency (CVID), were also observed in a genetically related asymptomatic disorder – selective IgA deficiency (IgAD). In this study we searched for abnormalities in the differentiation stages of T cells as well as for similarities of these abnormalities in CVID and IgAD patients.
Material and methods: Using flow cytometry in 80 patients with IgAD, 48 patients with CVID, and 80 control persons we determined T-lymphocyte subsets: both CD4 and CD8 were divided into the naïve CD45RO–CD27+, early differentiated CD45RO+CD27+, late differentiated CD45RO+CD27– and fully differentiated effector CD45RO–CD27– memory T cells, as well as Treg cells, defined as CD4+CD25highCD127low T cells.
Results: An increase of CD4+ and CD8+ late differentiated memory cells was observed comparing CVID patients to controls, as well as comparing IgAD patients to controls. In CVID patients an increase of CD4+ early differentiated memory cells, a decrease of CD8+ intermediate memory cells, and CD4+ and CD8+ naïve cells were found as well. The abnormalities in IgAD patients might be explained by higher CMV seropositivity observed in our IgAD. We confirmed the repeatedly published decrease of Treg cells in CVID patients, while Treg cells in IgAD patients were increased compared to controls.
Conclusions: Our results show T-cell activation not only in CVID, but also in IgAD patients. The increase in IgAD patients may be influenced by a more frequent CMV infection in our group of IgAD patients.
REFERENCES (42)
1.
Latiff AH, Kerr MA (2007): The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 44: 131-139.
2.
Cunningham-Rundles C (2001): Physiology of IgA and IgA deficiency. J Clin Immunol 21: 303-309.
3.
Chapel H, Cunningham-Rundles C (2009): Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol 145: 709-727.
4.
Cunningham-Rundles C, Bodian C (1999): Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92: 34-48.
5.
Quinti I, Soresina A, Spadaro G, et al. (2007): Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 27: 308-316.
6.
Abolhassani H, Amirkashani D, Parvaneh N, et al. (2013): Autoimmune phenotype in patients with common variable immunodeficiency. J Investig Allergol Clin Immunol 23: 323-329.
7.
Hammarström L, Vorechovsky I, Webster D (2000): Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120: 225-231.
8.
Rezaei N, Abolhassani H, Kasraian A, et al. (2013): Family study of pediatric patients with primary antibody deficiencies. Iran J Allergy Asthma Immunol 12: 377-382.
9.
Wright JJ, Wagner DK, Blaese RM, et al. (1990): Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 76: 2046-2051.
10.
Nechvatalova J, Pikulova Z, Stikarovska D, et al. (2012): B-lymphocyte Subpopulations in Patients with Selective IgA Deficiency. J Clin Immunol 32: 441-448.
11.
Vlková M, Thon V, Sárfyová M, et al. (2006): Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients. Clin Exp Immunol 143: 373-379.
12.
Litzman J, Vlková M, Pikulová Z, et al. (2007): T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency. Clin Exp Immunol 147: 249-254.
13.
Jaffe JS, Strober W, Sneller MC (1993): Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. Blood 82: 192-201.
14.
Melo KM, Carvalho KI, Bruno FR, et al. (2009): A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS One 4: e6269.
15.
Mouillot G, Carmagnat M, Gérard L, et al. (2010): B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 30: 746-755.
16.
Arandi N, Mirshafiey A, Jeddi-Tehrani M, et al. (2013): Evaluation of CD4+CD25+FOXP3+ regulatory T cells function in patients with common variable immunodeficiency. Cell Immunol 281: 129-133.
17.
Aukrust P, Frøland SS, Müller F (1992): Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features. Clin Exp Immunol 89: 211-216.
18.
Litzman J, Nechvatalova J, Xu J, et al. (2012): Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin Exp Immunol 170: 321-332.
19.
Young JL, Ramage JM, Gaston JS, Beverley PC (1997): In vitro responses of human CD45R0brightRA- and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Eur J Immunol 27: 2383-2390.
20.
Hamann D, Baars PA, Rep MH, et al. (1997): Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186: 1407-1418.
21.
Sallusto F, Lenig D, Förster R, et al. (1999): Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
22.
Maenetje P, Riou C, Casazza JP, et al. (2010): A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. J Immunol 184: 4926-4935.
23.
Conley ME, Notarangelo LD, Etzioni A (1999): Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93: 190-197.
24.
Liu W, Putnam AL, Xu-Yu Z, et al. (2006): CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
25.
Thongpan M, Kitiyakara C, Louischaroen Y, et al. (2009): Analysis of Foxp3, CD25, and CD127 expressed on regulatory T cells in Thai subjects. Asian Pac J Allergy Immunol 27: 137-145.
26.
Horn J, Manguiat A, Berglund LJ, et al. (2009): Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 156: 446-454.
27.
Libri V, Azevedo RI, Jackson SE, et al. (2011): Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4+CD45RA+CD27+ T cells: the potential involvement of interleukin-7 in this process. Immunology 132: 326-339.
28.
Mackus WJ, Frakking FN, Grummels A, et al. (2003): Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Blood 102: 1057-1063.
29.
Bateman EA, Ayers L, Sadler R, et al. (2012): T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 170: 202-211.
30.
Giovannetti A, Pierdominici M, Mazzetta F, et al. (2007): Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 178: 3932-3943.
31.
Warnatz K, Denz A, Dräger R, et al. (2002): Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99: 1544-1551.
32.
Burgers WA, Riou C, Mlotshwa M, et al. (2009): Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J Immunol 182: 4751-4761.
33.
Marashi SM, Raeiszadeh M, Enright V, et al. (2012): Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. J Allergy Clin Immunol 129: 1349-1356.e3.
34.
Papagno L, Spina CA, Marchant A, et al. (2004): Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2: E20.
35.
Shen CY, Chang WW, Chang SF, et al. (1992): Seroepidemiology of cytomegalovirus infection among children between the ages of 4 and 12 years in Taiwan. J Med Virol 37: 72-75.
36.
Mustakangas P, Sarna S, Ammälä P, et al. (2000): Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol 29: 587-591.
37.
Sakaguchi S. (2004): Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
38.
Cools N, Ponsaerts P, Van Tendeloo VF, Berneman ZN (2007): Regulatory T cells and human disease. Clin Dev Immunol 2007: 89195.
39.
Soheili H, Abolhassani H, Arandi N, et al. (2013): Evaluation of natural regulatory T cells in subjects with selective IgA deficiency: from senior idea to novel opportunities. Int Arch Allergy Immunol 160: 208-214.
40.
Freguja R, Gianesin K, Mosconi I, et al. (2011): Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children. Clin Exp Immunol 164: 373-380.
41.
Punkosdy GA, Blain M, Glass DD, et al. (2011): Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc Natl Acad Sci U S A 108: 3677-3682.
42.
Yu GP, Chiang D, Song SJ, et al. (2009): Regulatory T cell dysfunction in subjects with common variable immunodeficiency complicated by autoimmune disease. Clin Immunol 131: 240-253.